Treatment of Pain with Spirocylic Cyclohexane Derivatives Having Dual Specificity for ORL-1 and μ-Opioid Receptors

DOI: 10.1021/acsmedchemlett.6b00277

Full-Text   Cite this paper   Add to My Lib

Abstract:

The author declares no competing financial interest

Full-Text